NANOFOCUS O.N. INH O.N./ DE000A3H2242 /
28/05/2024 8:03:04 | Diferencia 0.000 | Volumen | Bid8:03:04 | Ask8:03:04 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
0.240EUR | 0.00% | 0 Volumen de negocios: 0.000 |
0.240Volumen de oferta: 0 | 0.500Tamaño/ Volumen/ Formato de Ask: 0 | 0.240 | 0.240 |
GlobeNewswire
13:32
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire
13:31
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
GlobeNewswire
13:30
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire
13:30
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire
13:30
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire
13:30
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
13:30
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire
13:30
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
13:30
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
13:30
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire
13:26
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire
13:26
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire
13:10
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página